I had a full body MRI scan this week at Royal Marsden in London. The purpose was to assess the effectiveness of docetaxel after 3 infusions. The results have been very disappointing, and I'm struggling to keep a sense of perspective - not least because I was feeling so good, and had seen all of my previous symptoms (bladder discomfort, pain in rectal wall, and more) disappear. I'll try and be brief (questions to you all in brackets):
1. My PSA has risen after falling during infusion #2 - a fall from 32 to 25, now risen to 34.
2. The ALP has gone down - from 380 prior to chemo to 193 after 3 infusions. The conclusion is that the Doce is working well for mets in bones but is actually making local tumour in the prostate worse (has this been anyone else's experience? Is there something about Doce that works better on bones than organs?)
3. The recommendation is that we switch to Cabazitaxel (Q: Has anyone had experience - positive or negative - of switching?)
4. A single spot on the liver now has a friend - a tiny 2nd spot has appeared. (Q Should I be really concerned (I am), or is the systemic nature of chemo going to address this?)
5. I've been so lucky with Docetaxel in avoiding any significant side effects (Q: What SEs can I expect from Cab?)
6. The enlarged tumour is causing pressure on the ureter, which is leading to hydronephrosis. They are recommending a stent, presumably until we can reduce the prostate. (Q: Is it bonkers to think that the prostate could be reduced through surgery?)
7. I am awaiting the genomic analysis of a biopsy to see if there might be other treatments available to me. If the Cab doesn't work, I'm considering Lu-177 (Q: Would the chemo experience so far affect the prospects for Lu 177?)
Any thoughts you have would be welcomed. I have some big decisions to make.....